Dabur Pharma
- All
- News
- Videos
-
Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies
Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.
-
Dabur Inks Pact With Govt to Make 2 Drugs
Dabur is planning to commercially produce the drugs within 6 months.
-
Dabur to Submit Additional Information for Alwar Unit to US Regulator
Homegrown FMCG major Dabur on Tuesday said the US Food and Drug Administration has sought "additional information" for its Alwar unit and the company is "in process of submitting the same".
-
Government to Set Up New Drug Regulator for Traditional Medicines
The government on Thursday said it is seeking to increase sales of India's ayurvedic and other traditional therapies in the estimated $100-billion global market for alternative medicine and plans to set up a new quality control regulator.
-
Sensex at day's low, Nifty in the red; Maruti falls
The markets pared the early gains they made, on strong Asian shares and as Unilever made an open offer to raise its stake in its Indian unit, to trade at their day's lows.
-
Ajanta Pharma Ltd - Ajanta Pharma Signs Agreement with Dabur Assigning its Flagship Brand 30-Plus
Ajanta Pharma Ltd has informed BSE regarding a Press Release dated May 03, 2011 titled "Ajanta Pharma Signs Agreement with Dabur Assigning its Flagship Brand 30-Plus".
-
Dabur India Ltd - Dabur Acquires 30-Plus Brand From Ajanta Pharma
Dabur India Ltd has informed BSE regarding a Press Release dated May 03, 2011 titled "Dabur Acquires �30-Plus' Brand From Ajanta Pharma".
-
Dabur India completes merger of Fem Care Pharma with itself
The board of Dabur India in its meeting on 18 June 2010 has approved the merger of Fem Care Pharma Ltd with the company. The company has fixed 30 June 2010 as the record date for allotment of Dabur India shares to Fem Care Pharma shareholders in the ratio of 5:1, (ie) 5 shares of Dabur India Ltd for every 1 Fem Care Pharma share held.The merger of ...
-
Fem Care Pharma hits record high as court approves merger with Dabur India
Fem Care Pharma rose 3.79% to Rs 864.90 at 12:06 IST on BSE after the Delhi High Court approved the company's merger with Dabur India, effective 1 April 2009.Meanwhile, the BSE Sensex was up 71.14 points, or 0.40%, to 17,764.34. On BSE, just 155 shares were traded in the counter as against an average daily volume of 666 shares in the past one quart...
-
Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies
Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.
-
Dabur Inks Pact With Govt to Make 2 Drugs
Dabur is planning to commercially produce the drugs within 6 months.
-
Dabur to Submit Additional Information for Alwar Unit to US Regulator
Homegrown FMCG major Dabur on Tuesday said the US Food and Drug Administration has sought "additional information" for its Alwar unit and the company is "in process of submitting the same".
-
Government to Set Up New Drug Regulator for Traditional Medicines
The government on Thursday said it is seeking to increase sales of India's ayurvedic and other traditional therapies in the estimated $100-billion global market for alternative medicine and plans to set up a new quality control regulator.
-
Sensex at day's low, Nifty in the red; Maruti falls
The markets pared the early gains they made, on strong Asian shares and as Unilever made an open offer to raise its stake in its Indian unit, to trade at their day's lows.
-
Ajanta Pharma Ltd - Ajanta Pharma Signs Agreement with Dabur Assigning its Flagship Brand 30-Plus
Ajanta Pharma Ltd has informed BSE regarding a Press Release dated May 03, 2011 titled "Ajanta Pharma Signs Agreement with Dabur Assigning its Flagship Brand 30-Plus".
-
Dabur India Ltd - Dabur Acquires 30-Plus Brand From Ajanta Pharma
Dabur India Ltd has informed BSE regarding a Press Release dated May 03, 2011 titled "Dabur Acquires �30-Plus' Brand From Ajanta Pharma".
-
Dabur India completes merger of Fem Care Pharma with itself
The board of Dabur India in its meeting on 18 June 2010 has approved the merger of Fem Care Pharma Ltd with the company. The company has fixed 30 June 2010 as the record date for allotment of Dabur India shares to Fem Care Pharma shareholders in the ratio of 5:1, (ie) 5 shares of Dabur India Ltd for every 1 Fem Care Pharma share held.The merger of ...
-
Fem Care Pharma hits record high as court approves merger with Dabur India
Fem Care Pharma rose 3.79% to Rs 864.90 at 12:06 IST on BSE after the Delhi High Court approved the company's merger with Dabur India, effective 1 April 2009.Meanwhile, the BSE Sensex was up 71.14 points, or 0.40%, to 17,764.34. On BSE, just 155 shares were traded in the counter as against an average daily volume of 666 shares in the past one quart...
